CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Clinical trials for CUTANEOUS LUPUS ERYTHEMATOSUS (CLE) explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS LUPUS ERYTHEMATOSUS (CLE) trials appear
Sign up with your email to follow new studies for CUTANEOUS LUPUS ERYTHEMATOSUS (CLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for multiple autoimmune diseases
Disease control Not yet recruitingThis early-stage study is testing a new drug called S-4321 in adults with autoimmune diseases like rheumatoid arthritis, psoriasis, lupus, or eczema. The main goal is to check the drug's safety, how the body processes it, and look for early signs it might help control these condi…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Phase: PHASE1 • Sponsor: Seismic Therapeutic AU Pty Ltd • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New lupus drug begins first human safety tests
Disease control Not yet recruitingThis is an early-stage study to check the safety and side effects of a new injection called HC022 in people with lupus. Researchers will give different doses to 32 adult volunteers with lupus to see how their bodies handle the drug and to look for any problems. The main goal is t…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New pill tested to tame painful skin lupus rash
Disease control Not yet recruitingThis study is testing whether an oral medication called ICP-488 can safely reduce the severity of skin rashes in people with cutaneous lupus erythematosus (CLE), a form of lupus that affects the skin. About 105 adults with moderate-to-severe skin lupus will be randomly assigned t…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Phase: PHASE2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
New pill aims to tame painful lupus skin flares in major trial
Disease control Not yet recruitingThis study aims to see if a new oral medication called enpatoran is effective and safe for treating active skin rashes caused by lupus. It will involve about 202 adults with cutaneous lupus, who may or may not also have systemic lupus. Participants will take either the study drug…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC